Hepion Pharmaceuticals HEPA
OTC HEPA
$0.10 -0.04 (-28.57%)
At close: Nov 13, 2026 · 4:00 PM EST

Hepion Pharmaceuticals (HEPA) EBIT Margin (2024 - 2026)

Updated

Hepion Pharmaceuticals' EBIT Margin was -19405.59% in Q2 2026, up 16465.99 percentage points from -35871.58% a year earlier.

Analysis

Hepion Pharmaceuticals (HEPA) EBIT Margin (2024 - 2026) Analysis & Trends

From Q2 2024 onward, Hepion Pharmaceuticals has reported EBIT Margin for 4 quarters.

  • Quarterly EBIT Margin has moved between -35871.58% (Q2 2025) and -6504.46% (Q3 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 10.44%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 19.44%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 18.08%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 17.44%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 6.36%
10 Hepion Pharmaceuticals 1.62 Mn -6.76 Mn - -19,405.59%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19,405.59%
Sep 30, 2025 -6,504.46%
Jun 30, 2025 -35,871.58%
Jun 30, 2024 -17,167.01%
API Access

Hepion Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=HEPA&period=max&api_key=YOUR_API_KEY